{"id":42971,"date":"2014-07-10T08:07:11","date_gmt":"2014-07-10T12:07:11","guid":{"rendered":"http:\/\/www.hedgeco.net\/news\/?p=42971"},"modified":"2014-07-10T08:07:11","modified_gmt":"2014-07-10T12:07:11","slug":"smart-biotech-hedge-fund-worth-watching-had-therapeutics-md-before-pop","status":"publish","type":"post","link":"https:\/\/hedgeco.net\/news\/07\/2014\/smart-biotech-hedge-fund-worth-watching-had-therapeutics-md-before-pop.html","title":{"rendered":"Smart Biotech Hedge Fund Worth Watching Had Therapeutics MD Before Pop"},"content":{"rendered":"<p>Forbes &#8211; Biotech stock Therapeutics MD (TXMD) was up 32.5% on Tuesday, lifted by brokerage house FBR Capital initiating coverage with an incredible $34 price target. Based on TXMD\u2019s Tuesday closing price of $5.47, the FBR price target would mean a 600% return.<\/p>\n<p>TXMD is owned by the billion-dollar biotech hedge fund RA Capital Management. RA is experienced in the business of biotech investing, and owns more than 6% of TXMD.<\/p>\n<p><a href=\"http:\/\/www.forbes.com\/sites\/greatspeculations\/2014\/07\/09\/smart-biotech-hedge-fund-worth-watching-had-therapeutics-md-before-pop\/\" target=\"_blank\"><strong>Read Complete Article<\/strong><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Forbes &#8211; Biotech stock Therapeutics MD (TXMD) was up 32.5% on Tuesday, lifted by brokerage house FBR Capital initiating coverage with an incredible $34 price target. Based on TXMD\u2019s Tuesday closing price of $5.47, the FBR price target would mean [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"class_list":["post-42971","post","type-post","status-publish","format-standard","hentry","category-syndicated"],"_links":{"self":[{"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/posts\/42971","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/comments?post=42971"}],"version-history":[{"count":1,"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/posts\/42971\/revisions"}],"predecessor-version":[{"id":42972,"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/posts\/42971\/revisions\/42972"}],"wp:attachment":[{"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/media?parent=42971"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/categories?post=42971"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/tags?post=42971"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}